Merck Group

Merck acquires AmpTec to expand mRNA capabilities for vaccines, treatments and diagnostics. Adds to Merck's lipid manufacturing expertise, providing an integrated offering across mRNA value chain

This profiles provides a brief background on Merck's organic photovoltaic material's business and progress